Dimethylformamide

Dimethylformamide

SCHEMBL277571

CN(C)C=O.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Dimethylformamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108570041-B Preparation method of isoxazoline-containing uracil compound 沈阳中化农药化工研发有限公司 2024-02-09 CN claimed
US-11014028-B2 Method for preparation and activation of super-hydrophobic electret fiber material for cleaning PM2.5 SOUTH CHINA UNIVERSITY OF TECHNOLOGY 2021-05-25 US claimed
US-10577535-B2 Substantially solid acidizing composition for treatment of subterranean formations HALLIBURTON ENERGY SERVICES, INC. (US) 2020-03-03 US claimed
US-20190143254-A1 Method for Preparation and Activation of Super-Hydrophobic Electret Fiber Material for Cleaning PM2.5 SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) 2019-05-16 US claimed
CN-109721577-A A kind of purification process of furans dicarboxylic acids 中国科学院宁波材料技术与工程研究所 2019-05-07 CN claimed
CN-105168130-B A kind of tumour target polymer micella and preparation method thereof 安徽医科大学 2017-10-27 CN claimed
US-20160272879-A1 SUBSTANTIALLY SOLID ACIDIZING COMPOSITION FOR TREATMENT OF SUBTERRANEAN FORMATIONS HALLIBURTON ENERGY SERVICES, INC. 2016-09-22 US claimed
CN-104140112-B The ion process for thermosynthesizing of a kind of microspheroidal porous alkali formula magnesium borate and magnesium borate nano-superstructure QUFU NORMAL UNIVERSITY (CN) 2016-06-01 CN claimed
WO-2015126397-A1 SUBSTANTIALLY SOLID ACIDIZING COMPOSITION FOR TREATMENT OF SUBTERRANEAN FORMATIONS HALLIBURTON ENERGY SERVICES, INC. (US) 2015-08-27 WO claimed
EP-1212273-B1 METHOD FOR PURIFYING ACID CHLORIDES BASF AG (DE) 2005-02-02 EP claimed
CN-1174954-C Method for purifying acid chlorides �����ɷ� 2004-11-10 CN claimed
US-6727384-B1 PREPARED BY REACTION OF CARBOXYLIC ACID WITH PHOSGENE OR THIONYL CHLORIDE; TREATING WITH CARBOXAMIDE HYDROHALIDE; SEPARATION BASF AKTIENGESELLSCHAFT (DE) 2004-04-27 US claimed
CN-1373743-A Method for purifying phosgene BASF AG (DE) 2002-10-09 CN claimed
WO-2001072704-A1 AZETIDINONE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND A METHOD FOR PRODUCING 1-β-ALKYL AZETIDINONE USING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2001-10-04 WO claimed
EP-0000609-A1 Novel 19-nor-pregnahexaenes, process for the preparation thereof, and pharmaceutical compositions containing them Technobiotic Ltd. (CH) 1979-02-07 EP claimed
US-3948966-A METAL CHLORIDE-DIMETHYLFORMAMIDE CATALYSTS KAO SOAP CO., LTD. (JA) 1976-04-06 US claimed
JP-2064129-A None JP disclosed
EP-4709708-A1 NOVEL CARBOXAMIDE DERIVATIVES ANGELINI PHARMA S.P.A. (IT) 2026-03-18 EP disclosed
US-3948966-A METAL CHLORIDE-DIMETHYLFORMAMIDE CATALYSTS KAO SOAP CO., LTD. (JA) 1976-04-06 US disclosed
US-3884631-A PREPARATION OF CELLULOSE N,N-DIMETHYLFORMIMIDATE CHLORIDE IN TEXTILE FORM, AND CONVERSION TO HALOGENODEOXYCELLULOSES AND CELLULOSE FORMATE US AGRICULTURE 1975-05-20 US disclosed